Arch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)
01 oct. 2024 14h24 HE
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Wound Cleanser Product Market to Surpass US$ 2.24 Billion, Expanding at a 1.4% CAGR by 2034: Fact.MR
25 sept. 2024 06h00 HE
|
FACT.MR
Rockville, MD, Sept. 25, 2024 (GLOBE NEWSWIRE) -- According to a new industry report released by Fact.MR, the global wound cleanser product market is estimated at US$ 1.96 billion in 2024 and is...
Remedium Healthcare Products Launches NuVeria Labs' Groundbreaking Sacral Silicone Dressing, Now Available for Purchase on Amazon Prime
19 avr. 2024 19h44 HE
|
Remedium Healthcare Products
Remedium Healthcare Products announces the launch of NuVeria Labs' Sacral Silicone Dressing on Amazon, setting a new standard in accessible, advanced wound
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray
31 janv. 2024 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™...
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium
25 janv. 2024 12h03 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) today announces that the Company will be presenting its...
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
21 nov. 2023 07h45 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Strengthens Board with Biotech Executive
16 nov. 2023 13h45 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) is pleased to announce that John Coleman has been...
Arch Therapeutics Provides Year End Operational Update
09 nov. 2023 06h50 HE
|
Arch Therapeutics, Inc.
Fiscal year-end AC5 Advanced Wound System update includes Q4 record monthly order volumes, favorable reimbursement decisions and increases in paid claims.
Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve™ Antimicrobial Wound Gel at Advanced Wound Care Fall Forum
02 nov. 2023 11h48 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today...
[Latest] Global Biofilms Treatment Market Size/Share Worth USD 3.5 Billion by 2032 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
05 sept. 2023 16h30 HE
|
Custom Market Insights
Austin, TX, USA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Biofilms Treatment Market Size, Trends and Insights By Product (Debridement...